03:30 AM EDT, 09/13/2024 (MT Newswires) -- Zenas BioPharma (ZBIO) said late Thursday it priced its upsized initial public offering of about 13.2 million shares at $17 apiece for gross proceeds of about $225 million.

The biopharmaceutical company, which launched its IPO in August, granted underwriters a 30-day option to buy up to about 2 million additional shares at the offering price.

Zenas' stock is expected to begin trading on Nasdaq this Friday, under the ticker symbol, "ZBIO."

The IPO is expected to close Sept. 16.